Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Satu Koivula, Minna Taskinen, Ping Chen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppa

Forskningsoutput: TidskriftsbidragMötesabstraktPeer review

Originalspråkengelska
TidskriftBlood
Volym116
Utgåva21
Sidor (från-till)1281-1281
Antal sidor1
ISSN0006-4971
StatusPublicerad - 19 nov 2010
Evenemang52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando
Varaktighet: 4 dec 20107 dec 2010

Citera det här